NEW YORK (360Dx) ­– Meridian Bioscience announced today that its Magellan Diagnostics subsidiary has signed an exclusive distribution agreement with Biofirm Technologies to provide Magellan's blood lead testing system in parts of Africa.

Biofirm distributes lab supplies in East and Central Africa.

Magellan offers the LeadCare II test, a US Food and Drug Administration-cleared and CLIA waived portable system for lead testing that takes three minutes to run and requires only two drops of whole blood.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Feb
27

In this webinar, Jill Viles, an Iowa mother with no clinical training, shares her story of how she self-diagnosed her rare condition, a muscle-wasting disease caused by a mutation in the LMNA gene. She will also discuss how she discovered that a mutation in the same gene is the underlying cause for the excess muscle phenotype exhibited by Canadian Olympic hurdler Priscilla Lopes-Schliep.